Listen to The Lancet

Carolyn Paul discusses new insights into a sea voyage to Calcutta undertaken by Lancet founder Thomas Wakley when he was just 11 years old.

Nick Watts and guests discuss progress on The Lancet Countdown to Climate Change project at an interim meeting held in London on March 13–14, 2017.

Rebecca Cooney and Aaron van Dorn with insight and analysis about the new US Administration’s proposal for health care reform: the American Health Care Act.

Ruth Webster from the George Institute in Sydney, Australia, discusses the potential of polypills to prevent atherosclerosis as part of a wider plan to meet non-communicable disease targets by 2025.

Emily Mendenhall discusses a new Lancet Series, explaining the new health concept of syndemics and how it can be used to tackle health inequities.

Subra Kugathasan discusses his Article which creates a risk-stratification model to predict the risk of developing complications in paediatric patients with newly diagnosed Crohn’s disease.

Majid Ezzati discusses Projections for increases in life expectancy in most of the world’s developed nations by 2030, and the implications for social policy.

Jennifer Downs discusses her Article on the influence of religious leaders in promoting male circumcision as a strategy to decrease HIV transmission in Tanzania.

Melanie Davies and Sudesna Chatterjee discuss a Seminar on type 2 diabetes, and outline plans for a Lancet Diabetes Commission.

Silvia Stringhini discusses a research article which highlights how low socioeconomic status should be considered alongside other established risk factors for non-communicable diseases.

Dr. Meredith Shiels discusses trends in premature mortality in the US since 1999.

John Neoptolomos discusses the ESPAC-4 trial, investigating a chemotherapy drug combination for patients with pancreatic cancer.

Hashim Ahmed discusses his study about the diagnostic accuracy of multi-parametric MRI in detecting clinically significant prostate cancer in men.

Ilze Bot discusses the link between stress, shown by amygdalar activity, and cardiovascular events.

Vikas Saini discusses a new Lancet Series, which aims to improve global health care through an emphasis on reducing overuse and underuse of medical treatment.

Marie-Paule Kieny outlines encouraging final results of the rVSV-ZEBOV Ebola vaccine trial from Guinea.

Naaheed Mukadam reads her winning Wakley Prize essay, entitled "Stay with me"; an account about the diagnosis and care of a patient with dementia and his spouse.

Sibylle Loibl discusses recent advances in the treatment of oestrogen receptor positive, HER2-positive, and triple-negative breast cancers.

Max Ortiz-Catalan discusses his trial of using augmented reality, motor execution technology to help treat patients with phantom limb pain.

Jeff Cohen from the Cleveland Clinic Lerner School of Medicine discusses the Series—recent therapeutic progress, and remaining challenges.

A joint podcast from Kaiser Health News and The Lancet – discussion of where US health policy might be heading when Donald Trump takes office early next year.

Nick Watts discusses the Lancet Countdown paper about importance of climate change to health, and tracking alterations to create positive changes for human health.

David Himmelstein looks ahead to US health policy challenges in light of the shock US election result.

Discussion of the US election, and of the importance of underlying social determinants of health for the US health policy environment.

Ophira Ginsburg discusses her Series about women's cancers, summarising what the needs are, disparities between regions, and this topic as an unmet global health issue.